Pulmonx Corporation (NASDAQ:LUNG) Q1 2022 Results Earnings Conference Call May 3, 2022 4:30 PM ET

Company Participants

Brian Johnston - VP, Investor Relations, Gilmartin Group

Glendon French - President & Chief Executive Officer

Derrick Sung - Chief Financial Officer

Conference Call Participants

Travis Steed - Bank of America

Cecilia Furlong - Morgan Stanley

Operator

Thank you for standing by, and welcome to the Pulmonx Q1 2022 Earnings Conference Call. At this time, all participants are in a listen-only. After the speakers there will be a question-and-answer session. [Operator Instructions] As a reminder, today's call is being recorded.

I would now like to turn the call over to your host, Mr. Brian Johnston, at the Gilmartin Group. Sir, you may begin.

Brian Johnston

Thanks, operator. Good afternoon, and thank you all for participating in today's call. Joining me from Pulmonx are Glendon French, President and Chief Executive Officer; and Derrick Sung, Chief Financial Officer. Earlier today, Pulmonx released financial results for the quarter ended March 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements, including without limitation, those relating to our operating trends and future financial performance, the impact of COVID-19 on our business and prospects for recovery, expense management, expectations for hiring, growth in our organization, market opportunity, guidance for revenue, gross margin and operating expenses, commercial expansion and product pipeline development are based upon our current estimates and various assumptions.

These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements.

For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our public filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K filed with the SEC on March 1, 2022. This conference call contains time sensitive information and is accurate only as of the live broadcast today, May 3, 2022.